Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical

04/08/2021 07:00

Aug 4 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1.97                2.13             9.10     
                                     (-22.2 pct)                  
  Operating      loss 47 mln        loss 213 mln        60 mln    
  Recurring      loss 23 mln        loss 179 mln        80 mln    
  Net              44 mln              33 mln           290 mln   
                 (+32.6 pct)                                      
  EPS             1.29 yen            0.97 yen         8.36 yen   
  Ann Div                                NIL                      
  -Q2 div                                NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T